Cargando…
Selenoprotein S: a therapeutic target for diabetes and macroangiopathy?
Inflammatory response, oxidative stress, and endoplasmic reticulum (ER) stress are important pathophysiological bases of the occurrence and development of diabetes mellitus (DM) and macroangiopathy complications. Selenoprotein S (SELENOS) is involved in the regulation of these mechanisms; therefore,...
Autores principales: | Yu, Shan-shan, Du, Jian-ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553675/ https://www.ncbi.nlm.nih.gov/pubmed/28797256 http://dx.doi.org/10.1186/s12933-017-0585-8 |
Ejemplares similares
-
The Effect of Chromium Picolinate Supplementation on the Pancreas and Macroangiopathy in Type II Diabetes Mellitus Rats
por: Huang, Shan, et al.
Publicado: (2014) -
Characterization of lncRNA and mRNA profiles in rats with diabetic macroangiopathy
por: Yang, Chan, et al.
Publicado: (2020) -
Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy
por: González-Clemente, José M., et al.
Publicado: (2022) -
MELAS and macroangiopathy: A case report and literature review
por: Sun, Xiangrong, et al.
Publicado: (2018) -
Macroangiopathy is a positive predictive factor for response to immunotherapy
por: Deike-Hofmann, Katerina, et al.
Publicado: (2019)